Teleflex Incorporated (NYSE:TFX) Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp reduced its position in Teleflex Incorporated (NYSE:TFX) by 24.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,689 shares of the medical technology company’s stock after selling 4,003 shares during the quarter. Mackenzie Financial Corp’s holdings in Teleflex were worth $3,164,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Invesco Ltd. raised its position in shares of Teleflex by 23.3% in the third quarter. Invesco Ltd. now owns 621,445 shares of the medical technology company’s stock valued at $122,058,000 after buying an additional 117,401 shares during the last quarter. TD Asset Management Inc grew its stake in Teleflex by 2.5% during the 3rd quarter. TD Asset Management Inc now owns 481,840 shares of the medical technology company’s stock valued at $94,638,000 after acquiring an additional 11,796 shares in the last quarter. Northern Trust Corp raised its holdings in Teleflex by 4.3% in the 3rd quarter. Northern Trust Corp now owns 457,170 shares of the medical technology company’s stock valued at $89,793,000 after acquiring an additional 19,001 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Teleflex by 1.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 393,053 shares of the medical technology company’s stock worth $77,200,000 after purchasing an additional 4,415 shares in the last quarter. Finally, LGT Capital Partners LTD. boosted its holdings in shares of Teleflex by 285.4% during the 4th quarter. LGT Capital Partners LTD. now owns 257,864 shares of the medical technology company’s stock worth $64,296,000 after purchasing an additional 190,950 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Royal Bank of Canada reduced their price objective on Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Truist Financial cut their target price on Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research note on Friday, February 23rd. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. Finally, JMP Securities restated a “market outperform” rating and set a $285.00 price objective on shares of Teleflex in a research report on Friday, February 23rd. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $267.50.

Teleflex Trading Up 0.3 %

Shares of TFX stock opened at $207.27 on Tuesday. Teleflex Incorporated has a 1-year low of $177.63 and a 1-year high of $276.43. The firm has a market cap of $9.76 billion, a PE ratio of 27.53, a price-to-earnings-growth ratio of 1.98 and a beta of 1.11. The company has a 50-day moving average of $224.58 and a two-hundred day moving average of $225.66. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.32 and a quick ratio of 1.29.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, topping analysts’ consensus estimates of $3.26 by $0.12. The firm had revenue of $773.90 million during the quarter, compared to analysts’ expectations of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the company posted $3.52 EPS. On average, analysts predict that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were issued a $0.34 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 annualized dividend and a dividend yield of 0.66%. Teleflex’s dividend payout ratio is presently 18.06%.

Insider Buying and Selling

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of Teleflex stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the completion of the transaction, the vice president now directly owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.43% of the stock is owned by corporate insiders.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.